Google Übersetzer
Lixte Biotechnology Holdings, Inc.
About
5.04USD+0.04 +0.80%
Closed • Updated at 21:48 GMT+00:00Market Cap$58.55M
Volume89.5K
Beta3.06
RSI71.57
Lixte Biotechnology Holdings, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Today
LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update
Apr 20 2026
LIXTE Biotechnology Holdings (LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape
Apr 13 2026
LIXTE Biotechnology (LIXT) Reports Interim Ovarian Cancer Trial Results at SGO Conference
Apr 10 2026
Lixte Biotech Holdings (LIXT) Advances Precision Oncology Strategy With LB-100, Expands Clinical and Strategic Partnerships
Apr 2 2026
LIXTE Biotechnology Holdings (LIXT) Files 2025 Form 10-K, Highlights Transformational Year
Recent Videos
Advancing Precision Cancer Treatments & AI-Driven Healthcare
Apr 24, 2026
Rare Earth Exploration, Precision Cancer Treatment, and Biotech Advancements
Apr 24, 2026
Evolving Precision Oncology Strategies
Apr 18, 2026
Mining and Biotech Updates: Gold Extraction, Signal Intelligence Framework, Clinical Trials, and ...
Apr 14, 2026